These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 28270010

  • 1. Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 - Part I.
    Bailey JJ, Schirrmacher R, Farrell K, Bernard-Gauthier V.
    Expert Opin Ther Pat; 2017 Jun; 27(6):733-751. PubMed ID: 28270010
    [Abstract] [Full Text] [Related]

  • 2. Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 - Part II.
    Bailey JJ, Schirrmacher R, Farrell K, Bernard-Gauthier V.
    Expert Opin Ther Pat; 2017 Jul; 27(7):831-849. PubMed ID: 28270021
    [Abstract] [Full Text] [Related]

  • 3. Trk kinase inhibitors as new treatments for cancer and pain.
    Wang T, Yu D, Lamb ML.
    Expert Opin Ther Pat; 2009 Mar; 19(3):305-19. PubMed ID: 19441906
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Targeting TRK family proteins in cancer.
    Khotskaya YB, Holla VR, Farago AF, Mills Shaw KR, Meric-Bernstam F, Hong DS.
    Pharmacol Ther; 2017 May; 173():58-66. PubMed ID: 28174090
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pyrazolo[1,5-a]pyrimidine as a Prominent Framework for Tropomyosin Receptor Kinase (Trk) Inhibitors-Synthetic Strategies and SAR Insights.
    Mahajan AT, Shivani, Datusalia AK, Coluccini C, Coghi P, Chaudhary S.
    Molecules; 2024 Jul 29; 29(15):. PubMed ID: 39124968
    [Abstract] [Full Text] [Related]

  • 8. Tropomyosin receptor kinase inhibitors: a patent update 2009 - 2013.
    McCarthy C, Walker E.
    Expert Opin Ther Pat; 2014 Jul 29; 24(7):731-44. PubMed ID: 24809946
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis and biological evaluation of macrocyclic derivatives as TRK inhibitors.
    Li P, Cai S, Zhao T, Xu L, Guan D, Li J, Zhou J, Zhang H.
    Bioorg Med Chem Lett; 2021 Dec 01; 53():128409. PubMed ID: 34628036
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Type II & III inhibitors of tropomyosin receptor kinase (Trk): a 2020-2022 patent update.
    Iliev P, Jaworski C, Wängler C, Wängler B, Page BDG, Schirrmacher R, Bailey JJ.
    Expert Opin Ther Pat; 2024 Apr 01; 34(4):231-244. PubMed ID: 38785069
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Discovery of the Next-Generation Pan-TRK Kinase Inhibitors for the Treatment of Cancer.
    Liu Z, Yu P, Dong L, Wang W, Duan S, Wang B, Gong X, Ye L, Wang H, Tian J.
    J Med Chem; 2021 Jul 22; 64(14):10286-10296. PubMed ID: 34253025
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.